Copyright: ©Author(s) 2026.
Figure 5 The impact of Yinchen Wuling San on the diversity of the intestinal microbiota in rats (n = 6).
A: Venn diagram; B: Rarefaction curve; C: Shannon-Wiener curve; D: Observed; E: Chao1; F: Ace; G: Shannon; H: Simpson; I: Pielou; J: Analysis of similarity analysis control vs model; K: Analysis of similarity analysis Yinchen Wuling San vs model; L: Analysis of similarity analysis Bifidobacterium quadruple live bacteria tablets vs model; M: Posterior communicating artery analysis. aP < 0.05 vs control, bP < 0.01 vs control, cP < 0.05 vs model, eP < 0.05 vs Yinchen Wuling San, fP < 0.01 vs Yinchen Wuling San. YCWLS: Yinchen Wuling San; CBLT: Bifidobacterium quadruple live bacteria tablets.
- Citation: Zhang Y, Liu J, Huang AS, Wang YF, Cao J, Li ML, Shi DD, Hu YL, Deng Q, Long P, Ai BC. Yinchen Wuling San ameliorates high-fat diet-induced metabolic-associated fatty liver disease in rats by remodeling the gut microbiota. World J Hepatol 2026; 18(6): 118607
- URL: https://www.wjgnet.com/1948-5182/full/v18/i6/118607.htm
- DOI: https://dx.doi.org/10.4254/wjh.118607